XML 86 R73.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Instruments, Hedging Activities and Fair Value - Derivatives Designated as Hedging Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Derivative [Line Items]        
Product Revenues $ 447,281 $ 350,898 $ 846,122 $ 680,800
Interest Expense (14,953) (6,103) (27,602) (11,610)
Income From Discontinued Businesses (524) (9,936) (299) (23,686)
Amount of gain or reclassified from AOCI into income (695)   26  
Interest rate swaps | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Interest Expense (732) 271 (1,110) 572
Income from discontinued business 0 (2,741) 0 (2,741)
Cross-currency interest rate swaps | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Interest Expense (295) (303) (600) (617)
Foreign currency exchange forward contracts | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Cost of services sold 0 44 0 44
Product Revenues | Interest rate swaps        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income 0      
Amount of gain or reclassified from AOCI into income   0    
Product Revenues | Foreign exchange contracts        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income 332   1,736  
Amount of gain or reclassified from AOCI into income   433 465  
Amount excluded from effectiveness testing recognized in earnings 13   196  
Amount excluded from effectiveness testing recognized in earnings   238 316  
Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 21   21  
Product Revenues | Cross-currency interest rate swaps        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income 0      
Amount of gain or reclassified from AOCI into income   0    
Interest Expense | Interest rate swaps        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income (732)   (1,110)  
Amount of gain or reclassified from AOCI into income   271   572
Interest Expense | Foreign exchange contracts        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income 0      
Amount of gain or reclassified from AOCI into income   0    
Amount excluded from effectiveness testing recognized in earnings 0      
Amount excluded from effectiveness testing recognized in earnings   0    
Interest Expense | Cross-currency interest rate swaps        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income (295)   (600)  
Amount of gain or reclassified from AOCI into income   (303)   (617)
Cost of services and products sold | Foreign currency exchange forward contracts        
Derivative [Line Items]        
Amount of gain or reclassified from AOCI into income (332)   (1,736)  
Amount of Gain Recognized in Income on Derivatives 1,736 2,770 7,278 5,094
Product Revenues        
Derivative [Line Items]        
Product Revenues 101,703 112,895 209,205 213,277
Cost of services sold 78,320 79,355 158,469 148,664
Products And Services, Service Revenue [Member]        
Derivative [Line Items]        
Product Revenues 345,578 238,003 636,917 467,523
Cost of services sold $ 285,822 186,840 $ 522,141 368,711
Amount of gain or reclassified from AOCI into income   $ (44)   $ (44)